Zevra Therapeutics Inc (NASDAQ:ZVRA) currently has a daily average trading volume of 567.35K but it saw 1585071 shares traded in last market. With a market cap of 514.53M USD, the company’s current market price of $9.41 came rising about 5.14 while comparing to the previous closing price of $8.95. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.76 and as low as $4.20. In the recent trading on the day.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on July 02, 2025, recommending a price target of $26 for it. Guggenheim also issued its recommendations for the stock as it initiated the price target for the stock is $20.
Over the week, ZVRA’s stock price is moving 0.86% up while it is 8.66% when we observe its performance for the past one month. Year-to-date it is 95.63% up and over the past year, the stock is showing an upside performance of 12.83%.
Currently, Zevra Therapeutics Inc’s total number of outstanding shares is 54.68M. Company’s return on investment (ROI) stands at -89.95% and return on equity (ROE) at -204.78%. It has a 14.39 of forward P/E ratio. Stock’s beta reads 1.85. Stock has a price to book (P/B) ratio of 12.54 while price to sale or P/S ratio amounts to 12.68. Its return on asset (ROA) is -56.78% on average.
#
